Breakthrough therapies still need builders
The next biopharma advantage will come from the talent and systems that turn discovery into scale.
Sources
- T2Breakthrough therapies still need buildersBioPharma Dive / Healthcare Dive / MedTech Dive
The next biopharma advantage will come from the talent and systems that turn discovery into scale.